Literature DB >> 8770168

Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney.

H Ikenaga1, R W Fallet, P K Carmines.   

Abstract

Experiments were performed to test the hypothesis that renal arteriolar vasoconstrictor responses to angiotensin II (ANG II) are curtailed through a mechanism that involves stimulation of endogenous nitric oxide (NO) synthesis. The in vitro blood-perfused juxtamedullary nephron technique was exploited to monitor arteriolar lumen diameter responses to exogenous ANG II before and during treatment with the NO synthase inhibitor N omega-nitro-L-arginine (L-NNA). Under control conditions, 1 nM ANG II reduced afferent and efferent arteriolar diameters by 13 and 11%, respectively. In the presence of L-NNA, 1 nM ANG II decreased afferent diameter by 26% and efferent diameter by 35%. This augmentation could not be attributed to the L-NNA-induced decrease in baseline diameter. L-NNA also augmented vasopressin responses, indicating a lack of agonist specificity in this interaction. ANG II reactivity during L-NNA treatment was not enhanced when tissue NO activity was fixed at basal levels (exposure to 1 microM sodium nitroprusside). These results indicate that endogenous NO modulates the vasoconstrictive impact of ANG II on both afferent and efferent arterioles of juxtamedullary nephrons and that this process does not require stimulation of NO synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770168     DOI: 10.1152/ajprenal.1996.271.2.F365

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Influence of Ca(2+)-activated K(+) channels on rat renal arteriolar responses to depolarizing agonists.

Authors:  R W Fallet; J P Bast; K Fujiwara; N Ishii; S C Sansom; P K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2001-04

2.  Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.

Authors:  Aaron J Polichnowski; Limin Lu; Allen W Cowley
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

3.  Effects of neuronal nitric oxide synthase inhibition on resting and exercising hindlimb muscle blood flow in the rat.

Authors:  Steven W Copp; Daniel M Hirai; Peter J Schwagerl; Timothy I Musch; David C Poole
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

4.  Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation.

Authors:  Marcela Herrera; Jeffrey L Garvin
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

5.  Predicted effects of nitric oxide and superoxide on the vasoactivity of the afferent arteriole.

Authors:  Anita T Layton; Aurélie Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-15

Review 6.  Endothelin and the renal microcirculation.

Authors:  Zhengrong Guan; Justin P VanBeusecum; Edward W Inscho
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

7.  Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin.

Authors:  Rachel W Fallet; Hideki Ikenaga; Joseph P Bast; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-09

8.  Src family kinase involvement in rat preglomerular microvascular contractile and [Ca2+]i responses to ANG II.

Authors:  Qi Che; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-30

9.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

10.  Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.

Authors:  Zhengrong Guan; Sean T Singletary; Anthony K Cook; Janet L Hobbs; Jennifer S Pollock; Edward W Inscho
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.